Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Clinical Efficacy and Safety of Luspatercept Combined With Low-dose Thalidomide Versus Luspatercept Alone in the Treatment of Adult Patients With Transfusion-dependent β-thalassemia

NCT07338344 is registered in ClinicalTrials.gov with Rongrong Liu as lead sponsor.

NCT NCT07338344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07338344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Clinical Efficacy and Safety of Luspatercept Combined With Low-dose Thalidomide Versus Luspatercept Alone in the Treatment of Adult Patients With Transfusion-dependent β-thalassemia
Lead sponsor
Rongrong Liu
Phase
Phase 2
Overall status
Recruiting
Start date
February 1, 2026
Completion date
December 31, 2027
Enrollment
78 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

transfusion-dependent β-thalassemia patients